Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer
Sign Up to like & getrecommendations! Published in 2020 at "Archives of Gynecology and Obstetrics"
DOI: 10.1007/s00404-020-05477-7
Abstract: Purpose Presence of circulating tumor cells (CTCs) is associated with impaired clinical outcome in several solid cancers. Limited data are available on the significance of CTCs in gynaecological malignancies. The aims of the present study… read more here.
Keywords: peritoneal cancer; tube peritoneal; fallopian tube; ovarian fallopian ... See more keywords
Clinical impact of pre‐treatment FDG‐PET/CT staging of primary ovarian, fallopian tube, and peritoneal cancers in women
Sign Up to like & getrecommendations! Published in 2019 at "Acta Obstetricia et Gynecologica Scandinavica"
DOI: 10.1111/aogs.13726
Abstract: To assess the clinical impact of preoperative fludeoxyglucose (FDG) with positron emission tomography (PET) and computed tomography (CT) in women with ovarian, fallopian tube, or peritoneal cancer with focus on consequences of added findings (AFs). read more here.
Keywords: tube peritoneal; fallopian tube; ovarian fallopian; fdg ... See more keywords
Validity of the 2014 FIGO Stage IIIA1 Subclassification for Ovarian, Fallopian Tube, and Peritoneal Cancers
Sign Up to like & getrecommendations! Published in 2022 at "In Vivo"
DOI: 10.21873/invivo.12980
Abstract: Abstract Background/Aim: The 2014 International Federation of Gynecology and Obstetrics (FIGO) classification subdivides patients with stage IIIA1 ovarian, fallopian tube, and peritoneal cancers by the greatest dimension of metastatic lymph node without supporting evidence. This… read more here.
Keywords: tube peritoneal; stage; fallopian tube; stage iiia1 ... See more keywords